State UT
Clinical Trials in Utah
Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Utah
Frequently Asked Questions — Clinical Trials in Utah
How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 183 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 183. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Advanced Solid Tumor, Breast Cancer, Non-Small Cell Lung Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Utah
NCT07207707 Phase 1
Recruiting
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Ad...
Condition
Solid Tumor Malignancies
Enrollment
78 pts
Location
United States
Sponsor
Kumquat Biosciences Inc.
NCT06326411 Phase 1
Recruiting
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjec...
Condition
Oncology
Enrollment
230 pts
Location
United States, Australia
Sponsor
Nested Therapeutics, Inc
NCT05005403 Phase 1
Recruiting
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With N...
Condition
Non-Small Cell Lung Cancer
Enrollment
694 pts
Location
United States, Canada, Israel
Sponsor
AbbVie
NCT01099982 N/A
Recruiting
Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart...
Condition
Congestive Heart Failure
Enrollment
300 pts
Location
United States
Sponsor
University of Utah
NCT07167927 N/A
Recruiting
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoli...
Condition
Children With Medical Complexity (CMC)
Enrollment
110 pts
Location
United States
Sponsor
University of Utah
NCT06868290 Phase 2
Recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Act...
Condition
ANCA Associated Vasculitis (AAV)
Enrollment
126 pts
Location
United States, Brazil, Israel
Sponsor
Novartis Pharmaceuticals
NCT06608823 N/A
Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Condition
Aortic Regurgitation
Enrollment
1,016 pts
Location
United States
Sponsor
JenaValve Technology, Inc.
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07226986 Phase 1, Phase 2
Recruiting
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetrax...
Condition
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Enrollment
123 pts
Location
United States, Australia, France
Sponsor
Novartis Pharmaceuticals
NCT05009992 Phase 2
Recruiting
Combination Therapy for the Treatment of Diffuse Midline Gliomas
Condition
Diffuse Intrinsic Pontine Glioma
Enrollment
360 pts
Location
United States, Australia, Israel
Sponsor
University of California, San
NCT07219771 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarth...
Condition
Knee Osteoarthritis
Enrollment
260 pts
Location
United States, Australia
Sponsor
Doron Therapeutics Inc.
NCT06253871 Phase 1
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Condition
HER2 Mutation-Related Tumors
Enrollment
383 pts
Location
United States, France, Ireland
Sponsor
Iambic Therapeutics, Inc
NCT06220864 Phase 1
Recruiting
SNV1521 in Participants With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
400 pts
Location
United States, Australia, Canada
Sponsor
Synnovation Therapeutics, Inc.
NCT06112418 N/A
Recruiting
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Pr...
Condition
Diabetes Mellitus, Type 2
Enrollment
7,500 pts
Location
United States
Sponsor
Cleerly, Inc.
NCT00198068 N/A
Recruiting
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiph...
Condition
Systemic Lupus Erythematosus
Enrollment
700 pts
Location
United States, Canada, United Kingdom
Sponsor
Hospital for Special Surgery,
NCT06297226 Phase 2
Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Ther...
Condition
Multiple Myeloma
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
Juno Therapeutics, Inc., a Bri
NCT04884035 Phase 1
Recruiting
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R...
Condition
Lymphoma, B-Cell
Enrollment
224 pts
Location
United States, Australia, Greece
Sponsor
Celgene
NCT06001918 Phase 2, Phase 3
Recruiting
Nectero EAST System Clinical Study
Condition
Abdominal Aortic Aneurysm
Enrollment
400 pts
Location
United States, Australia, New Zealand
Sponsor
Nectero Medical, Inc.
NCT07276724 Phase 3
Recruiting
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With...
Condition
Severe Asthma
Enrollment
786 pts
Location
United States
Sponsor
Generate Biomedicines
NCT05929703 N/A
Recruiting
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized ...
Condition
Delirium
Enrollment
1,900 pts
Location
United States
Sponsor
University of Michigan
NCT04657068 Phase 1, Phase 2
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Condition
Advanced Cancer
Enrollment
442 pts
Location
United States, France, Spain
Sponsor
Artios Pharma Ltd
NCT06249048 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as...
Condition
Advanced Solid Tumor
Enrollment
108 pts
Location
United States, Australia
Sponsor
Strand Therapeutics Inc.
NCT07287917 Phase 1, Phase 2
Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced S...
Condition
Melanoma (Skin Cancer)
Enrollment
92 pts
Location
United States
Sponsor
Aminex Therapeutics, Inc.
NCT06336655 Phase 2
Recruiting
Physiology of Unloading VA ECMO Trial
Condition
Cardiogenic Shock
Enrollment
104 pts
Location
United States
Sponsor
University of Utah
NCT05913908 N/A
Recruiting
EFS of the DUO System for Tricuspid Regurgitation
Condition
Tricuspid Regurgitation
Enrollment
15 pts
Location
United States, Poland
Sponsor
CroiValve Limited
Page 1 of 8 — 183 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology